Walker P D, Kaushal G P, Shah S V
Department of Pathology, University of Arkansas for Medical Sciences, Little Rock.
J Am Soc Nephrol. 1994 Jul;5(1):55-61. doi: 10.1681/ASN.V5155.
Renal tubular homogenates incubated with [3H]laminin (2 micrograms, 10(5) cpm) at 37 degrees C resulted in time- and protein-dependent laminin degradation (e.g., at 24 h, control = 6,533 +/- 771; experimental = 27,610 +/- 1,023 cpm +/- SE; N = 20). Gel chromatography confirmed that laminin (800 to 900 kd) was degraded to 20- to 50-kd fragments. Laminin degradation was not significantly decreased by serine or cysteine protease inhibitors. In contrast, metal chelators produced marked inhibition (EDTA, 93 +/- 3%; 1,10-phenanthroline, 99 +/- 1%) indicating that, at neutral pH, metalloproteinases were responsible for the laminin degradation. Laminin-degrading activity in renal tubules was not inhibited by the tissue inhibitor of metalloproteinase and was present in an active form. This activity was also present in high concentrations in the renal cortex and medulla but was only minimal in the liver. Further studies of the renal cortex revealed a similar metalloproteinase activity against type IV collagen (11,075 +/- 305; N = 6) and gelatin (41,026 +/- 1,373; N = 6), and this activity was membrane associated (97 +/- 1%; N = 4). Taken together, the characteristics of this renal metalloproteinase indicate that it is distinct from classic matrix-degrading metalloproteinases. The release of this distinct metalloproteinase from damaged renal tubular epithelial cells during injury may result in the production of fragments of laminin or other extracellular matrix components with biologic effects relevant to renal regeneration.
肾小管匀浆与[3H]层粘连蛋白(2微克,10⁵ 每分钟计数)在37℃孵育,导致层粘连蛋白出现时间和蛋白质依赖性降解(例如,24小时时,对照 = 6533 ± 771;实验 = 27610 ± 1023每分钟计数 ± 标准误;N = 20)。凝胶色谱法证实层粘连蛋白(800至900千道尔顿)被降解为20至50千道尔顿的片段。丝氨酸或半胱氨酸蛋白酶抑制剂并未显著降低层粘连蛋白的降解。相反,金属螯合剂产生了显著抑制作用(乙二胺四乙酸,93 ± 3%;1,10 - 菲咯啉,99 ± 1%),表明在中性pH条件下,金属蛋白酶负责层粘连蛋白的降解。肾小管中层粘连蛋白降解活性不受金属蛋白酶组织抑制剂的抑制,且以活性形式存在。这种活性在肾皮质和髓质中也以高浓度存在,但在肝脏中含量极少。对肾皮质的进一步研究显示,针对IV型胶原(11075 ± 305;N = 6)和明胶(41026 ± 1373;N = 6)存在类似的金属蛋白酶活性,且这种活性与膜相关(97 ± 1%;N = 4)。综上所述,这种肾金属蛋白酶的特性表明它与经典的基质降解金属蛋白酶不同。在损伤过程中,这种独特的金属蛋白酶从受损的肾小管上皮细胞释放,可能导致产生具有与肾再生相关生物学效应的层粘连蛋白或其他细胞外基质成分的片段。